Filing Details

Accession Number:
0001209191-22-029923
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-18 11:04:05
Reporting Period:
2022-05-17
Accepted Time:
2022-05-18 11:04:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1117480 Chimerix Inc CMRX Pharmaceutical Preparations (2834) 330903395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1698751 T. Michael Andriole 2505 Meridian Parkway, Suite 100
Durham NC 27713
Chief Business Officer And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-17 15,000 $1.71 212,724 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.705 to $1.71, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
  2. Includes: i) 13,273 shares acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") on September 10, 2020; ii) 17,361 shares acquired under the Issuer's ESPP on March 10, 2021; and iii) 17,361 shares acquired under the Issuer's ESPP on March 10, 2022.